In DSS-induced colitis models, baicalein treatment upregulates key anti-ferroptotic defense molecules, including glutathione peroxidase 4 (GPX4), the cystine/glutamate antiporter subunit SLC7A11, and the transcription factor Nrf2. This evidence concerns the gene GPX4 and colitis.